Sign in

CIK 0001427925 · Non-accelerated filer<br>Smaller reporting company

TALPHERA, INC.

Sign in to watch
Ticker
TLPH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
412193603
Phone
650-216-3500
Business address
1850 GATEWAY DRIVE, SUITE 175, SAN MATEO, CA, 94404
Former names
ACELRX PHARMACEUTICALS INC
  1. 4 Grant or award Chief Engineering Officer acquired 14,667 shares (grant or award)
  2. 4 Grant or award Chief Financial Officer acquired 18,000 shares (grant or award)
  3. 4 Grant or award Chief Executive Officer acquired 58,667 shares (grant or award)
  4. 4 Shares withheld for taxes Chief Engineering Officer gave up 1,618 shares (to pay taxes)
  5. 4 Shares withheld for taxes Chief Medical Officer gave up 1,602 shares (to pay taxes)
  6. 4 Shares withheld for taxes Chief Financial Officer gave up 1,790 shares (to pay taxes)
  7. 4 Shares withheld for taxes Chief Executive Officer gave up 7,043 shares (to pay taxes)
  8. 4 Derivatives Options or other derivatives
  9. 4 Grant or award Director acquired 871 shares (grant or award)
  10. 3 Insider Initial Statement of Ownership
  11. 3 Insider Initial Statement of Ownership
  12. 4 Open-market buy Chief Executive Officer bought 10,000 shares at $0.73 ($7,268)
  13. 4 Grant or award Director acquired 581 shares (grant or award)
  14. 4 Grant or award Director acquired 581 shares (grant or award)
  15. 4 Grant or award Director acquired 581 shares (grant or award)
  16. 4 Grant or award Director acquired 581 shares (grant or award)
  17. 4 Grant or award Director acquired 581 shares (grant or award)
  18. 4 Grant or award Director acquired 581 shares (grant or award)
  19. 4 Grant or award Director acquired 581 shares (grant or award)
  20. 4 Open-market buy Chief Executive Officer bought 10,000 shares at $0.80 ($7,950)

Page 4 of 21 · 404 filings